| Doreen M Norberg, NP | |
|
100 South St, Southbridge, MA 01550-4051 | |
| (508) 765-9771 | |
| (508) 909-7735 |
| Full Name | Doreen M Norberg |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 29 Years |
| Location | 100 South St, Southbridge, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427100478 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrington Memorial Hospital-1 | Southbridge, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
Participating in community service activities and helping others is not just good for the soul; it has a healing effect that helps alcoholics and other addicts become and stay sober, a researcher from Case Western Reserve University School of Medicine reports.
As President Barack Obama is pilloried for the rocky rollout of the law, the White House struggles with how to refocus the public's attention, since some of the strongest arguments for the law are longer-term benefits that are harder to comprehend.
Nearly one in three children admitted to pediatric intensive care will experience delusions or hallucinations, which put them at higher risk for post-traumatic stress symptoms, according to a new study of children's experiences in a pediatric intensive care unit (PICU).
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
› Verified 1 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
Participating in community service activities and helping others is not just good for the soul; it has a healing effect that helps alcoholics and other addicts become and stay sober, a researcher from Case Western Reserve University School of Medicine reports.
As President Barack Obama is pilloried for the rocky rollout of the law, the White House struggles with how to refocus the public's attention, since some of the strongest arguments for the law are longer-term benefits that are harder to comprehend.
Nearly one in three children admitted to pediatric intensive care will experience delusions or hallucinations, which put them at higher risk for post-traumatic stress symptoms, according to a new study of children's experiences in a pediatric intensive care unit (PICU).
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
› Verified 1 days ago
| Entity Name | Harrington Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346420874 PECOS PAC ID: 2567543689 Enrollment ID: O20080115000505 |
News Archive
Participating in community service activities and helping others is not just good for the soul; it has a healing effect that helps alcoholics and other addicts become and stay sober, a researcher from Case Western Reserve University School of Medicine reports.
As President Barack Obama is pilloried for the rocky rollout of the law, the White House struggles with how to refocus the public's attention, since some of the strongest arguments for the law are longer-term benefits that are harder to comprehend.
Nearly one in three children admitted to pediatric intensive care will experience delusions or hallucinations, which put them at higher risk for post-traumatic stress symptoms, according to a new study of children's experiences in a pediatric intensive care unit (PICU).
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Doreen M Norberg, NP 100 South St, Southbridge, MA 01550-4051 Ph: (508) 765-9771 | Doreen M Norberg, NP 100 South St, Southbridge, MA 01550-4051 Ph: (508) 765-9771 |
News Archive
Participating in community service activities and helping others is not just good for the soul; it has a healing effect that helps alcoholics and other addicts become and stay sober, a researcher from Case Western Reserve University School of Medicine reports.
As President Barack Obama is pilloried for the rocky rollout of the law, the White House struggles with how to refocus the public's attention, since some of the strongest arguments for the law are longer-term benefits that are harder to comprehend.
Nearly one in three children admitted to pediatric intensive care will experience delusions or hallucinations, which put them at higher risk for post-traumatic stress symptoms, according to a new study of children's experiences in a pediatric intensive care unit (PICU).
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
› Verified 1 days ago